Gabelli & Co Investment Advisers’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ISLE Stock Details ISLE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-97,700	Closed	-$973K	–	513
2022 Q2	$973K	Hold	97,700	–	–	0.13%	124
2022 Q1	$967K	Hold	97,700	–	–	0.13%	130
2021 Q4	$961K	Hold	97,700	–	–	0.13%	122
2021 Q3	$960K	Hold	97,700	–	–	0.12%	131
2021 Q2	$957K	Hold	97,700	–	–	0.11%	128
2021 Q1	$947K	Buy	+97,700	New	+$944K	0.12%	128

Gabelli & Co Investment Advisers's ISLE Position: Q3 2022 in Review

Gabelli & Co Investment Advisers sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 97,700 shares — an estimated $973K sold.

Gabelli & Co Investment Advisers first reported a position in ISLE in Q1 2021 and held it in 6 quarters. The position peaked at $973K in Q2 2022. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

Gabelli & Co Investment Advisers reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 97,700 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $973K.
Gabelli & Co Investment Advisers first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q1 2021 and held it in 6 quarters.
Gabelli & Co Investment Advisers's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $973K in Q2 2022.
0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.